Skip to main content
Erschienen in: Cardiovascular Toxicology 2/2022

03.11.2021

Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population

verfasst von: Saeed Elahirad, Daniel Elieh Ali Komi, Amir Kiani, Ehsan Mohammadi-Noori, Asad Vaisi‑Raygani, Hadi Mozafari, Fariborz Bahrehmand, Mohammadreza Saidi, Vahid Toupchi-Khosroshahi, Nahid Salehi

Erschienen in: Cardiovascular Toxicology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The serum levels and activity of matrix metalloproteinases (MMPs) are associated with the risk of coronary artery calcification (CAC). We sought to investigate the association between MMP-2 -1575G>A (rs243866) and MMP-9 -1562 C>T (rs3918242) SNPs with MMP-2 and MMP-9 serum levels and activity in individuals with CAC. One hundred and fifty-five cases with CAC and 155 healthy individuals as control group from West of Iran were included and frequency of genotypes and alleles of rs243866 and rs3918242 in MMP-2 and MMP-9 genes were determined using PCR–RFLP. We also investigated the serum levels of MMP-2 and MMP-9 and their activity using ELISA and gelatin zymography, respectively. Additionally, serum biochemical parameters including FBS (fasting blood sugar), urea, creatinine, cholesterol, triglyceride, HDL (high-density lipoprotein), LDL (low-density lipoprotein), calcium, and phosphorus as well as blood pressure (systolic blood pressure (SBP) and diastolic blood pressure (DBP)) were measured. Our results showed that both serum levels of MMP-2 and MMP-9 (P < 0.001) and their activity (P < 0.001) were higher in individuals with CAC when compared to the control group. Carrying A and T alleles in MMP-2 -1575G>A (rs243866) and MMP-9 -1562 C>T (rs3918242) SNPs, respectively, may predispose the individuals to CAC by acting as the risk factors. Serum levels and activity of MMP-2 and MMP-9 were found to be higher in CAC cases when compared to the healthy controls. Carriers of A allele in rs243866 SNP and T allele in rs3918242 SNP were shown to have higher MMP-2 and MMP-9 serum levels and activity that may result in increased ECM degradation and support the initiation and development of calcification.
Literatur
1.
Zurück zum Zitat Liu, W., Zhang, Y., Yu, C. M., Ji, Q. W., Cai, M., Zhao, Y. X., & Zhou, Y. J. (2015). Current understanding of coronary artery calcification. Journal of Geriatric Cardiology: JGC, 12, 668–675. PubMedPubMedCentral Liu, W., Zhang, Y., Yu, C. M., Ji, Q. W., Cai, M., Zhao, Y. X., & Zhou, Y. J. (2015). Current understanding of coronary artery calcification. Journal of Geriatric Cardiology: JGC, 12, 668–675. PubMedPubMedCentral
2.
Zurück zum Zitat Mohammadi-Noori, E., Salehi, N., Mozafari, H., EliehAliKomi, D., Saidi, M., Bahrehmand, F., Vaisi-Raygani, A., Elahirad, S., Moini, A., & Kiani, A. (2020). Association of AHSG gene polymorphisms with serum Fetuin-A levels in individuals with cardiovascular calcification in west of Iran. Molecular Biology Reports, 47, 1809–1820. PubMed Mohammadi-Noori, E., Salehi, N., Mozafari, H., EliehAliKomi, D., Saidi, M., Bahrehmand, F., Vaisi-Raygani, A., Elahirad, S., Moini, A., & Kiani, A. (2020). Association of AHSG gene polymorphisms with serum Fetuin-A levels in individuals with cardiovascular calcification in west of Iran. Molecular Biology Reports, 47, 1809–1820. PubMed
3.
Zurück zum Zitat Hillerson, D., Wool, T., Ogunbayo, G. O., Sorrell, V. L., & Leung, S. W. (2020). Incidental coronary artery calcification and stroke risk in patients with atrial fibrillation. AJR: American Journal of Roentgenology, 215, 1–7. Hillerson, D., Wool, T., Ogunbayo, G. O., Sorrell, V. L., & Leung, S. W. (2020). Incidental coronary artery calcification and stroke risk in patients with atrial fibrillation. AJR: American Journal of Roentgenology, 215, 1–7.
4.
Zurück zum Zitat Wang, L., Jerosch-Herold, M., Jacobs, D. R., Jr., Shahar, E., Detrano, R., & Folsom, A. R. (2006). Coronary artery calcification and myocardial perfusion in asymptomatic adults: The MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 48, 1018–1026. PubMedPubMedCentral Wang, L., Jerosch-Herold, M., Jacobs, D. R., Jr., Shahar, E., Detrano, R., & Folsom, A. R. (2006). Coronary artery calcification and myocardial perfusion in asymptomatic adults: The MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 48, 1018–1026. PubMedPubMedCentral
5.
Zurück zum Zitat Mori, H., Torii, S., Kutyna, M., Sakamoto, A., Finn, A. V., & Virmani, R. (2018). Coronary artery calcification and its progression: what does it really mean? CJACC Cardiovascular Imaging, 11, 127–142. PubMed Mori, H., Torii, S., Kutyna, M., Sakamoto, A., Finn, A. V., & Virmani, R. (2018). Coronary artery calcification and its progression: what does it really mean? CJACC Cardiovascular Imaging, 11, 127–142. PubMed
6.
Zurück zum Zitat Joseph, T. P., Kotecha, N. S., Kumar, H. B. C., Jain, N., Kapoor, A., Kumar, S., Bhatia, E., Mishra, P., & Sahoo, S. K. (2020). Coronary artery calcification, carotid intima-media thickness and cardiac dysfunction in young adults with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 34, 107609. PubMed Joseph, T. P., Kotecha, N. S., Kumar, H. B. C., Jain, N., Kapoor, A., Kumar, S., Bhatia, E., Mishra, P., & Sahoo, S. K. (2020). Coronary artery calcification, carotid intima-media thickness and cardiac dysfunction in young adults with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 34, 107609. PubMed
7.
Zurück zum Zitat Motro, M., & Shemesh, J. (2001). Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension (Dallas, Tex.: 1979), 37, 1410–1413. Motro, M., & Shemesh, J. (2001). Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension (Dallas, Tex.: 1979), 37, 1410–1413.
8.
Zurück zum Zitat Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B. B., Hunt, J. R., Ludlam, S. E., Pettinger, M. B., Gass, M., Margolis, K. L., Nathan, L., Ockene, J. K., Prentice, R. L., Robbins, J., & Stefanick, M. L. (2007). Estrogen therapy and coronary-artery calcification. The New England Journal of Medicine, 356, 2591–2602. PubMed Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B. B., Hunt, J. R., Ludlam, S. E., Pettinger, M. B., Gass, M., Margolis, K. L., Nathan, L., Ockene, J. K., Prentice, R. L., Robbins, J., & Stefanick, M. L. (2007). Estrogen therapy and coronary-artery calcification. The New England Journal of Medicine, 356, 2591–2602. PubMed
9.
Zurück zum Zitat Kalil, R. S., Flanigan, M., Stanford, W., & Haynes, W. G. (2012). Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: A prospective pilot study. Clinical Nephrology, 78, 1–9. PubMed Kalil, R. S., Flanigan, M., Stanford, W., & Haynes, W. G. (2012). Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: A prospective pilot study. Clinical Nephrology, 78, 1–9. PubMed
10.
Zurück zum Zitat Chertow, G. M., Burke, S. K., & Raggi, P. (2002). Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney international, 62, 245–252. PubMed Chertow, G. M., Burke, S. K., & Raggi, P. (2002). Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney international, 62, 245–252. PubMed
11.
Zurück zum Zitat Chen, C. L., Chen, N. C., Wu, F. Z., & Wu, M. T. (2020). Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: A pilot study. Osteoporosis International, 31, 1507–1516. PubMed Chen, C. L., Chen, N. C., Wu, F. Z., & Wu, M. T. (2020). Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: A pilot study. Osteoporosis International, 31, 1507–1516. PubMed
12.
Zurück zum Zitat Elieh Ali Komi, D., & Grauwet, K. (2018). Role of mast cells in regulation of T cell responses in experimental and clinical settings. Clinical Reviews in Allergy & Immunology, 54, 432–445. Elieh Ali Komi, D., & Grauwet, K. (2018). Role of mast cells in regulation of T cell responses in experimental and clinical settings. Clinical Reviews in Allergy & Immunology, 54, 432–445.
13.
Zurück zum Zitat EliehAliKomi, D., Shafaghat, F., & Haidl, G. (2020). Significance of mast cells in spermatogenesis, implantation, pregnancy, and abortion: Cross talk and molecular mechanisms. American Journal of Reproductive Immunology (New York, N.Y.: 1989), 83, e13228. EliehAliKomi, D., Shafaghat, F., & Haidl, G. (2020). Significance of mast cells in spermatogenesis, implantation, pregnancy, and abortion: Cross talk and molecular mechanisms. American Journal of Reproductive Immunology (New York, N.Y.: 1989), 83, e13228.
14.
Zurück zum Zitat Komi, D. E. A., & Redegeld, F. A. (2020). Role of mast cells in shaping the tumor microenvironment. Clinical Reviews in Allergy & Immunology, 58, 313–325. Komi, D. E. A., & Redegeld, F. A. (2020). Role of mast cells in shaping the tumor microenvironment. Clinical Reviews in Allergy & Immunology, 58, 313–325.
15.
Zurück zum Zitat Komi, D. E. A., Khomtchouk, K., & Santa Maria, P. L. (2020). A review of the contribution of mast cells in wound healing: Involved molecular and cellular mechanisms. Clinical Reviews in Allergy & Immunology, 58, 298–312. Komi, D. E. A., Khomtchouk, K., & Santa Maria, P. L. (2020). A review of the contribution of mast cells in wound healing: Involved molecular and cellular mechanisms. Clinical Reviews in Allergy & Immunology, 58, 298–312.
16.
Zurück zum Zitat Rao, V. H., Lees, G. E., Kashtan, C. E., Nemori, R., Singh, R. K., Meehan, D. T., Rodgers, K., Berridge, B. R., Bhattacharya, G., & Cosgrove, D. (2003). Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney International, 63, 1736–1748. PubMed Rao, V. H., Lees, G. E., Kashtan, C. E., Nemori, R., Singh, R. K., Meehan, D. T., Rodgers, K., Berridge, B. R., Bhattacharya, G., & Cosgrove, D. (2003). Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney International, 63, 1736–1748. PubMed
17.
Zurück zum Zitat Najafi, K., Komi, D. E. A., Khazaie, H., Moini, A., Vaisi, A., Raygani, Ahmadi, H. R., Ghadami, M. R., & Kiani, A. (2019). Investigation of serum levels and activity of matrix metalloproteinases 2 and 9 (MMP2, 9) in opioid and methamphetamine-dependent patients. Acta Medica Iranica, 56, 559–562. Najafi, K., Komi, D. E. A., Khazaie, H., Moini, A., Vaisi, A., Raygani, Ahmadi, H. R., Ghadami, M. R., & Kiani, A. (2019). Investigation of serum levels and activity of matrix metalloproteinases 2 and 9 (MMP2, 9) in opioid and methamphetamine-dependent patients. Acta Medica Iranica, 56, 559–562.
18.
Zurück zum Zitat Mirabdaly, S., Elieh Ali Komi, D., Shakiba, Y., Moini, A., & Kiani, A. (2020). Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Molecular Biology Reports, 47, 1187–1197. PubMed Mirabdaly, S., Elieh Ali Komi, D., Shakiba, Y., Moini, A., & Kiani, A. (2020). Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Molecular Biology Reports, 47, 1187–1197. PubMed
19.
Zurück zum Zitat Chen, N. X., O’Neill, K. D., Chen, X., Kiattisunthorn, K., Gattone, V. H., & Moe, S. M. (2011). Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. American Journal of Nephrology, 34, 211–219. PubMedPubMedCentral Chen, N. X., O’Neill, K. D., Chen, X., Kiattisunthorn, K., Gattone, V. H., & Moe, S. M. (2011). Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. American Journal of Nephrology, 34, 211–219. PubMedPubMedCentral
20.
Zurück zum Zitat Radunovic, M., Nikolic, N., Milenkovic, S., Tomanovic, N., Boricic, I., Dimitrijevic, M., Novakovic, I., & Basta-Jovanovic, G. (2016). The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer. Journal of BUON, 21, 597–602. PubMed Radunovic, M., Nikolic, N., Milenkovic, S., Tomanovic, N., Boricic, I., Dimitrijevic, M., Novakovic, I., & Basta-Jovanovic, G. (2016). The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer. Journal of BUON, 21, 597–602. PubMed
21.
Zurück zum Zitat Singh, K., Agrawal, N. K., Gupta, S. K., & Singh, K. (2013). A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. The International Journal of Lower Extremity Wounds, 12, 199–204. PubMed Singh, K., Agrawal, N. K., Gupta, S. K., & Singh, K. (2013). A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. The International Journal of Lower Extremity Wounds, 12, 199–204. PubMed
22.
Zurück zum Zitat Habel, A. F., Ghali, R. M., Bouaziz, H., Daldoul, A., Hadj-Ahmed, M., Mokrani, A., Zaied, S., Hechiche, M., Rahal, K., Yacoubi-Loueslati, B., & Almawi, W. Y. (2019). Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women. Tumour Biology, 41, 1010428319845749. PubMed Habel, A. F., Ghali, R. M., Bouaziz, H., Daldoul, A., Hadj-Ahmed, M., Mokrani, A., Zaied, S., Hechiche, M., Rahal, K., Yacoubi-Loueslati, B., & Almawi, W. Y. (2019). Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women. Tumour Biology, 41, 1010428319845749. PubMed
23.
Zurück zum Zitat Ting, W. C., Chen, L. M., Pao, J. B., Yang, Y. P., You, B. J., Chang, T. Y., Lan, Y. H., Lee, H. Z., & Bao, B. Y. (2013). Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients. International Journal of Medical Sciences, 10, 1022–1027. PubMedPubMedCentral Ting, W. C., Chen, L. M., Pao, J. B., Yang, Y. P., You, B. J., Chang, T. Y., Lan, Y. H., Lee, H. Z., & Bao, B. Y. (2013). Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients. International Journal of Medical Sciences, 10, 1022–1027. PubMedPubMedCentral
24.
Zurück zum Zitat Tian, Y., An, F., Wang, J., Liu, C., Wu, H., Cao, Y., Wang, J., & Wang, G. (2019). MMP2 and MMP10 polymorphisms are related to steroid-induced osteonecrosis of the femoral head among Chinese Han population. BioMed Research International, 2019, 8298193. PubMedPubMedCentral Tian, Y., An, F., Wang, J., Liu, C., Wu, H., Cao, Y., Wang, J., & Wang, G. (2019). MMP2 and MMP10 polymorphisms are related to steroid-induced osteonecrosis of the femoral head among Chinese Han population. BioMed Research International, 2019, 8298193. PubMedPubMedCentral
25.
Zurück zum Zitat Chacon-Cortes, D., & Griffiths, L. (2014). Methods for extracting genomic DNA from whole blood samples: Current perspectives. Journal of Biorepository Science for Applied Medicine, 2, 1–9. Chacon-Cortes, D., & Griffiths, L. (2014). Methods for extracting genomic DNA from whole blood samples: Current perspectives. Journal of Biorepository Science for Applied Medicine, 2, 1–9.
26.
Zurück zum Zitat EliehAliKomi, D., Sadeghi-Shabestari, M., Shanebandi, D., Babaloo, Z., Razavi, A., Sadigh-Eteghad, S., & Kazemi, T. (2019). Investigation of chitinase3like-1 (Chiti3L1) gene polymorphism (rs4950928) with susceptibility to allergic asthma in Iranian Northwestern Azeri population. Research in Molecular Medicine, 7, 17–24. EliehAliKomi, D., Sadeghi-Shabestari, M., Shanebandi, D., Babaloo, Z., Razavi, A., Sadigh-Eteghad, S., & Kazemi, T. (2019). Investigation of chitinase3like-1 (Chiti3L1) gene polymorphism (rs4950928) with susceptibility to allergic asthma in Iranian Northwestern Azeri population. Research in Molecular Medicine, 7, 17–24.
27.
Zurück zum Zitat Aslanian-Kalkhoran, L., Elieh-Ali-Komi, D., Sadeghi-Shabestari, M., Shanebandi, D., Babaloo, Z., Razavi, A., Sadigh-Eteghad, S., & Kazemi, T. (2017). Investigation of Fc receptor-like 3 (FCRL-3) gene polymorphism (rs7528684) with susceptibility to allergic asthma in Iranian North-Western Azeri population. Clinical Laboratory, 63, 1301–1305. PubMed Aslanian-Kalkhoran, L., Elieh-Ali-Komi, D., Sadeghi-Shabestari, M., Shanebandi, D., Babaloo, Z., Razavi, A., Sadigh-Eteghad, S., & Kazemi, T. (2017). Investigation of Fc receptor-like 3 (FCRL-3) gene polymorphism (rs7528684) with susceptibility to allergic asthma in Iranian North-Western Azeri population. Clinical Laboratory, 63, 1301–1305. PubMed
28.
Zurück zum Zitat Rybakowski, J. K. (2009). Matrix metalloproteinase-9 (MMP9)—A mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovascular Psychiatry and Neurology, 2009, 904836. PubMedPubMedCentral Rybakowski, J. K. (2009). Matrix metalloproteinase-9 (MMP9)—A mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovascular Psychiatry and Neurology, 2009, 904836. PubMedPubMedCentral
29.
Zurück zum Zitat Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010). Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochimica et Biophysica Acta, 1803, 3–19. PubMed Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010). Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochimica et Biophysica Acta, 1803, 3–19. PubMed
30.
Zurück zum Zitat Bahrehmand, F., Vaisi-Raygani, A., Kiani, A., Rahimi, Z., Tavilani, H., Ardalan, M., Vaisi-Raygani, H., Shakiba, E., & Pourmotabbed, T. (2015). Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: Correlation with systemic inflammatory markers and oxidative stress. Lupus, 24, 597–605. PubMed Bahrehmand, F., Vaisi-Raygani, A., Kiani, A., Rahimi, Z., Tavilani, H., Ardalan, M., Vaisi-Raygani, H., Shakiba, E., & Pourmotabbed, T. (2015). Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: Correlation with systemic inflammatory markers and oxidative stress. Lupus, 24, 597–605. PubMed
31.
Zurück zum Zitat Lehmann, D. J., Williams, J., McBroom, J., & Smith, A. D. (2001). Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups. Neuroscience, 108, 541–554. PubMed Lehmann, D. J., Williams, J., McBroom, J., & Smith, A. D. (2001). Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups. Neuroscience, 108, 541–554. PubMed
32.
Zurück zum Zitat Raygani, A. V., Zahrai, M., Soltanzadeh, A., Doosti, M., Javadi, E., & Pourmotabbed, T. (2004). Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer’s disease. Neuroscience Letters, 371, 142–146. PubMed Raygani, A. V., Zahrai, M., Soltanzadeh, A., Doosti, M., Javadi, E., & Pourmotabbed, T. (2004). Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer’s disease. Neuroscience Letters, 371, 142–146. PubMed
33.
Zurück zum Zitat Shahmohamadnejad, S., Vaisi-Raygani, A., Shakiba, Y., Kiani, A., Rahimi, Z., Bahrehmand, F., Shakiba, E., & Pourmotabbed, T. (2015). Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report. Clinical Biochemistry, 48, 63–69. PubMed Shahmohamadnejad, S., Vaisi-Raygani, A., Shakiba, Y., Kiani, A., Rahimi, Z., Bahrehmand, F., Shakiba, E., & Pourmotabbed, T. (2015). Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report. Clinical Biochemistry, 48, 63–69. PubMed
34.
Zurück zum Zitat Wågsäter, D., Zhu, C., Björkegren, J., Skogsberg, J., & Eriksson, P. (2011). MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(−/−)Apob(100/100) mouse. International Journal of Molecular Medicine, 28, 247–253. PubMed Wågsäter, D., Zhu, C., Björkegren, J., Skogsberg, J., & Eriksson, P. (2011). MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(−/−)Apob(100/100) mouse. International Journal of Molecular Medicine, 28, 247–253. PubMed
35.
Zurück zum Zitat Soliman, A. R., Sadek, K. M., Thabet, K. K., Ahmed, D. H., & Mohamed, O. M. (2019). The role of matrix metalloproteinases 2 in atherosclerosis of patients with chronic kidney disease in type 2 diabetes. Saudi Journal of Kidney Diseases and Transplantation, 30, 387–393. PubMed Soliman, A. R., Sadek, K. M., Thabet, K. K., Ahmed, D. H., & Mohamed, O. M. (2019). The role of matrix metalloproteinases 2 in atherosclerosis of patients with chronic kidney disease in type 2 diabetes. Saudi Journal of Kidney Diseases and Transplantation, 30, 387–393. PubMed
36.
Zurück zum Zitat Qin, X., Corriere, M. A., Matrisian, L. M., & Guzman, R. J. (2006). Matrix metalloproteinase inhibition attenuates aortic calcification. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1510–1516. PubMed Qin, X., Corriere, M. A., Matrisian, L. M., & Guzman, R. J. (2006). Matrix metalloproteinase inhibition attenuates aortic calcification. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1510–1516. PubMed
37.
Zurück zum Zitat Liu, R., Chen, B., Chen, J., & Lan, J. (2018). Leptin upregulates smooth muscle cell expression of MMP-9 to promote plaque destabilization by activating AP-1 via the leptin receptor/MAPK/ERK signaling pathways. Experimental and Therapeutic Medicine, 16, 5327–5333. PubMedPubMedCentral Liu, R., Chen, B., Chen, J., & Lan, J. (2018). Leptin upregulates smooth muscle cell expression of MMP-9 to promote plaque destabilization by activating AP-1 via the leptin receptor/MAPK/ERK signaling pathways. Experimental and Therapeutic Medicine, 16, 5327–5333. PubMedPubMedCentral
38.
Zurück zum Zitat Kieffer, P., Giummelly, P., Schjoth, B., Carteaux, J. P., Villemot, J. P., Hornebeck, W., & Atkinson, J. (2001). Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification. Atherosclerosis, 157, 251–254. PubMed Kieffer, P., Giummelly, P., Schjoth, B., Carteaux, J. P., Villemot, J. P., Hornebeck, W., & Atkinson, J. (2001). Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification. Atherosclerosis, 157, 251–254. PubMed
39.
Zurück zum Zitat Harendza, S., Lovett, D. H., Panzer, U., Lukacs, Z., Kuhnl, P., & Stahl, R. A. (2003). Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. The Journal of Biological Chemistry, 278, 20490–20499. PubMed Harendza, S., Lovett, D. H., Panzer, U., Lukacs, Z., Kuhnl, P., & Stahl, R. A. (2003). Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. The Journal of Biological Chemistry, 278, 20490–20499. PubMed
40.
Zurück zum Zitat Dofara, S. G., Chang, S. L., & Diorio, C. (2020). Gene polymorphisms and circulating levels of MMP-2 and MMP-9: A review of their role in breast cancer risk. Anticancer Research, 40, 3619–3631. PubMed Dofara, S. G., Chang, S. L., & Diorio, C. (2020). Gene polymorphisms and circulating levels of MMP-2 and MMP-9: A review of their role in breast cancer risk. Anticancer Research, 40, 3619–3631. PubMed
41.
Zurück zum Zitat Zhen, G. D., Zhao, L. B., Wu, S. S., Chen, M. Y., Li, Z. H., Zhou, S. Z., & Li, Z. F. (2017). Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis. Bioscience Reports, 37, 4. Zhen, G. D., Zhao, L. B., Wu, S. S., Chen, M. Y., Li, Z. H., Zhou, S. Z., & Li, Z. F. (2017). Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis. Bioscience Reports, 37, 4.
42.
Zurück zum Zitat Rollin, J., Régina, S., Vourc’h, P., Iochmann, S., Bléchet, C., Reverdiau, P., & Gruel, Y. (2007). Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 56, 273–280. Rollin, J., Régina, S., Vourc’h, P., Iochmann, S., Bléchet, C., Reverdiau, P., & Gruel, Y. (2007). Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 56, 273–280.
43.
Zurück zum Zitat Hua, Y., Song, L., Wu, N., Lu, X., Meng, X., Gu, D., & Yang, Y. (2009). Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese. The American Journal of the Medical Sciences, 337, 344–348. PubMed Hua, Y., Song, L., Wu, N., Lu, X., Meng, X., Gu, D., & Yang, Y. (2009). Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese. The American Journal of the Medical Sciences, 337, 344–348. PubMed
44.
Zurück zum Zitat Beber, A. R., Polina, E. R., Biolo, A., Santos, B. L., Gomes, D. C., La Porta, V. L., Olsen, V., Clausell, N., Rohde, L. E., & Santos, K. G. (2016). Matrix metalloproteinase-2 polymorphisms in chronic heart failure: Relationship with susceptibility and long-term survival. PLoS ONE, 11, e0161666. PubMedPubMedCentral Beber, A. R., Polina, E. R., Biolo, A., Santos, B. L., Gomes, D. C., La Porta, V. L., Olsen, V., Clausell, N., Rohde, L. E., & Santos, K. G. (2016). Matrix metalloproteinase-2 polymorphisms in chronic heart failure: Relationship with susceptibility and long-term survival. PLoS ONE, 11, e0161666. PubMedPubMedCentral
45.
Zurück zum Zitat Pérez-Hernández, N., Vargas-Alarcón, G., Martínez-Rodríguez, N., Martínez-Ríos, M. A., Peña-Duque, M. A., Peña-Díaz Ade, L., Valente-Acosta, B., Posadas-Romero, C., Medina, A., & Rodríguez-Pérez, J. M. (2012). The matrix metalloproteinase 2–1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. Journal of Atherosclerosis and Thrombosis, 19, 718–727. PubMed Pérez-Hernández, N., Vargas-Alarcón, G., Martínez-Rodríguez, N., Martínez-Ríos, M. A., Peña-Duque, M. A., Peña-Díaz Ade, L., Valente-Acosta, B., Posadas-Romero, C., Medina, A., & Rodríguez-Pérez, J. M. (2012). The matrix metalloproteinase 2–1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. Journal of Atherosclerosis and Thrombosis, 19, 718–727. PubMed
46.
Zurück zum Zitat Wu, H. D., Bai, X., Chen, D. M., Cao, H. Y., & Qin, L. (2013). Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: A case–control study. Genetic Testing and Molecular Biomarkers, 17, 707–712. PubMedPubMedCentral Wu, H. D., Bai, X., Chen, D. M., Cao, H. Y., & Qin, L. (2013). Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: A case–control study. Genetic Testing and Molecular Biomarkers, 17, 707–712. PubMedPubMedCentral
47.
Zurück zum Zitat Saedi, M., Vaisi-Raygani, A., Khaghani, S., Shariftabrizi, A., Rezaie, M., Pasalar, P., Rahimi, Z., & Pourmotabbed, T. (2012). Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease. Molecular Biology Reports, 39, 555–562. PubMed Saedi, M., Vaisi-Raygani, A., Khaghani, S., Shariftabrizi, A., Rezaie, M., Pasalar, P., Rahimi, Z., & Pourmotabbed, T. (2012). Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease. Molecular Biology Reports, 39, 555–562. PubMed
48.
Zurück zum Zitat Bahrehmand, F., Vaisi-Raygani, A., Kiani, A., Rahimi, Z., Tavilani, H., Navabi, S. J., Shakiba, E., Hassanzadeh, N., & Pourmotabbed, T. (2012). Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Lupus, 21, 616–624. PubMed Bahrehmand, F., Vaisi-Raygani, A., Kiani, A., Rahimi, Z., Tavilani, H., Navabi, S. J., Shakiba, E., Hassanzadeh, N., & Pourmotabbed, T. (2012). Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Lupus, 21, 616–624. PubMed
49.
Zurück zum Zitat Reynolds, J. J. (1996). Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Diseases, 2, 70–76. PubMed Reynolds, J. J. (1996). Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Diseases, 2, 70–76. PubMed
50.
Zurück zum Zitat Elieh Ali Komi, D., & Bjermer, L. (2019). Mast cell-mediated orchestration of the immune responses in human allergic asthma: Current insights. Clinical Reviews in Allergy & Immunology, 56, 234–247. Elieh Ali Komi, D., & Bjermer, L. (2019). Mast cell-mediated orchestration of the immune responses in human allergic asthma: Current insights. Clinical Reviews in Allergy & Immunology, 56, 234–247.
Metadaten
Titel
Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population
verfasst von
Saeed Elahirad
Daniel Elieh Ali Komi
Amir Kiani
Ehsan Mohammadi-Noori
Asad Vaisi‑Raygani
Hadi Mozafari
Fariborz Bahrehmand
Mohammadreza Saidi
Vahid Toupchi-Khosroshahi
Nahid Salehi
Publikationsdatum
03.11.2021
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 2/2022
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-021-09707-5

Weitere Artikel der Ausgabe 2/2022

Cardiovascular Toxicology 2/2022 Zur Ausgabe